Found: 5
Select item for more details and to access through your institution.
Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 8, p. 1, doi. 10.1038/s41419-021-03937-9
- By:
- Publication type:
- Article
'Hippocampal innate inflammatory gliosis only' in pharmacoresistant temporal lobe epilepsy.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 2, p. 549, doi. 10.1093/brain/awac293
- By:
- Publication type:
- Article
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28523-1
- By:
- Publication type:
- Article
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28523-1
- By:
- Publication type:
- Article
Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1885, doi. 10.1093/neuonc/noab092
- By:
- Publication type:
- Article